Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
TFPI2 encodes a member of the Kunitz-type serine proteinase inhibitor family. Additionally we are shipping TFPI2 Kits (31) and TFPI2 Proteins (29) and many more products for this protein.
Showing 10 out of 116 products:
Human Polyclonal TFPI2 Primary Antibody for IHC, WB - ABIN2787607
Becker, Volland, Noskova, Schramm, Schweigerer, Wilting: Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: a mechanism to inhibit invasion. in International journal of oncology 2007
Human Polyclonal TFPI2 Primary Antibody for FACS, IF (p) - ABIN738306
Wang, Wang, Li, Li, Deng: Expression of tissue factor pathway inhibitor-2 in gastric stromal tumor and its clinical significance. in Experimental and therapeutic medicine 2014
Data show that silencing tumor-endothelial cells (EC) for trypsinogen 4 (show PRSS3 Antibodies) accumulated tissue factor pathway inhibitor-2 (TFPI-2) in the matrix.
Hypermethylation of TFPI2 promoter is increased in inflamed colon tissue.
DNA methylation of TFPI2 may play an important role in the carcinogenesis of cervical cancer and that the differential methylation of TFPI2 may at least partially explain the disparity in cervical cancer incidence between Uygur and Han women.
our findings suggested that the differential expression of MMP-2 (show MMP2 Antibodies) and TFPI-2 have a negative correlation in pancreatic carcinoma
Our finding suggests that the decreased expression of TFPI-2 may play an important role in the carcinogenesis and progression, and may become a new adjunct marker in the diagnosis and prognosis in cholangiocarcinoma
TMPRSS4 (show TMPRSS4 Antibodies) is upregulated by silencing of TFPI-2 through aberrant DNA methylation (show HELLS Antibodies) and contributes to oncogenesis in non-small cell lung cancer.
TFPI-2 is a down-regulated tumor suppressor gene in oral squamous cell carcinoma, probably involving epigenetic silencing mechanisms. The loss of TFPI-2 expression is a key event for oral tumorigenesis, especially in the process of tumor metastasis.
regulation of tissue factor pathway inhibitor-2 (TFPI-2) expression by lysine-specific demethylase (show MBD2 Antibodies) 1 and 2
TFPI-2 in platelets from normal or pregnant subjects and in plasma from pregnant women binds FV/Va and regulates intrinsic coagulation and fibrinolysis
TFPI-2 downregulation can contribute to tumor invasion of hepatocellular carcinoma cells through alteration in the expression of metastasis-related genes.
A novel mouse model is presented and can be used to investigate the role of TFPI-2 in the process of atherosclerosis.
Over-expression of TFPI-2 promotes atherosclerotic plaque stability, which may be related to inhibition of matrix metalloproteinases.
Bovine TFPI2 was compared to mouse TFPI2.
human and murine TFPI-2 have different functions in liver regulation during inflammation in the two species
Our data suggest that TFPI-2 may be an important regulator of aberrant angiogenesis associated with tumor growth/metastasis, cardiovascular diseases, chronic inflammation, or diabetes.
Deficiency for the histone methyltransferase EHMT2 (show EHMT2 Antibodies) or for the Polycomb group protein EED (show EED Antibodies), leads to biallelic expression of Tfpi2 in the extra-embryonic lineages, whereas the other genes in the cluster maintain correct imprinting.
Dynamic changes of Tfpi2 associated with Il-1beta (show IL1B Antibodies) and Tnf-alpha (show TNF Antibodies) in the development of acute lung injury are reported.
Bovine TFPI2 was cloned and its expression and characterization determined.
This gene encodes a member of the Kunitz-type serine proteinase inhibitor family. The protein can inhibit a variety of serine proteases including factor VIIa/tissue factor, factor Xa, plasmin, trypsin, chymotryspin and plasma kallikrein. This gene has been identified as a tumor suppressor gene in several types of cancer. Alternative splicing results in multiple transcript variants.
tissue factor pathway inhibitor 2
, tissue factor pathway inhibitor-2
, Tissue factor pathway inhibitor 2
, placental protein 5
, retinal pigment epithelium cell factor 1